The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines-Reference-Cited by-同舟云学术

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines

Published:2020-07 Issue:34 Volume:38 Page:5556-5561
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kim Denny,Robertson James S.,Excler Jean-Louis,Condit Richard C.,Fast Patricia E.,Gurwith Marc,Pavlakis George^ORCID,Monath Thomas P.,Smith Jonathan,Wood David,Smith Emily R.,Chen Robert T.^ORCID,Kochhar Sonali^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference13 articles.

1. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI);Bonhoeffer;Vaccine,2002

2. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG);Chen;Vaccine,2015

3. Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment;Monath;Vaccine,2015

4. Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment;Clarke;Vaccine,2016

5. rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment;Monath;Vaccine X,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine;Vaccine;2024-09

2. The Platform Technology Approach to mRNA Product Development and Regulation;Vaccines;2024-05-11

3. The Brighton collaboration standardized module for vaccine benefit-risk assessment;Vaccine;2023-12

4. Staphylococcus aureus vaccine strategy: Promise and challenges;Microbiological Research;2023-06

5. A qualitative study on health stigma and discrimination in the first year of the COVID-19 pandemic: Lessons learnt from a public health perspective;Frontiers in Public Health;2023-03-01